Marc A. Cohn

Marc Cohn is a first-chair jury trial litigator. For more than 20 years, he has been lead and co-lead trial counsel before juries, judges, and arbitration panels in cases involving patent infringement, contracts and license agreements, trade secret misappropriation, Lanham Act, unfair competition, and other business torts. He has examined dozens of witnesses on the stand, including experts on technical, medical, regulatory, economic, and accounting matters, as well as company executives, inventors, and sales/marketing personnel. He has also been co-lead in more than a half dozen Federal Circuit appeals, and has appeared before the United States Patent Office in inter partes review proceedings. Marc has managed multi-jurisdictional patent infringement wars involving claims in the U.S., Germany, UK, Netherlands, Ireland, and Canada. He has also participated in setting strategy for European Patent Office oppositions and attended EPO arguments.

With his academic background in Engineering Physics and electrical engineering, Marc understands technologies at a deep level, and has a talent for teaching complicated ideas to clients and factfinders.

Unlike many patent lawyers, who focus on technical issues, Marc understands that a jury decides cases based on their emotional connection to the client's witnesses as human beings. The jury needs to put themselves in the client's shoes, to feel their motivations and good intentions from a perspective of empathy. Marc identifies important human themes early in the case so as to set trial strategy based on the "story of our client."

In addition to litigation, Marc also advises clients on intellectual property valuation and litigation risk, including economic modelling of potential damages and claims. He has conducted these assessments in myriad contexts, e.g., as part of M&A due diligence, potential investments by large banks, potential suits that might be brought by or against our clients, and prosecution of new patent claims.

Marc has been retained as an "advocate in residence" for small companies to project-manage written submissions, oral presentations, and the building of expert teams on medical, statistical, and regulatory matters. His background in applied physics and statistics enables him to bridge the communication gap between technical experts and the outside world. Marc has drafted and delivered presentations on behalf of client executives for their Boards, investors, and employees, as well as to regulators, Congresspersons, and the public. He has project-managed key regulatory submissions to FDA, Health Canada, and the European Medicines Agency, and he has assisted in preparing SEC filings, drafted press releases, and reviewed medical journal manuscripts, among other forms of oral and written advocacy.